text:
Staphylococcus aureus
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Staphylococcus aureus
Scanning electron micrograph of S. aureus; false color added
Scientific classification
Domain: Bacteria
Kingdom: Eubacteria
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Staphylococcaceae
Genus: Staphylococcus
Species: S. aureus
Binomial name
Staphylococcus aureus
Rosenbach 1884
Staphylococcus aureus (also known as golden staph) is a gram-positive, round-shaped bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen.[1] Although S. aureus is not always pathogenic (and can commonly be found existing as a commensal), it is a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. Despite much research and development there is no approved vaccine for S. aureus.
Staphylococcus was first identified in 1880 in Aberdeen, Scotland, by surgeon Sir Alexander Ogston in pus from a surgical abscess in a knee joint.[2] This name was later amended to Staphylococcus aureus by Friedrich Julius Rosenbach,[3] who was credited by the official system of nomenclature at the time. An estimated 20% to 30% of the human population are long-term carriers of S. aureus[4][5] which can be found as part of the normal skin flora, in the nostrils,[4][6] and as a normal inhabitant of the lower reproductive tract of women.[7][8] S. aureus can cause a range of illnesses, from minor skin infections, such as pimples,[9] impetigo, boils, cellulitis, folliculitis, carbuncles, scalded skin syndrome, and abscesses, to life-threatening diseases such as pneumonia, meningitis, osteomyelitis, endocarditis, toxic shock syndrome, bacteremia, and sepsis. It is still one of the five most common causes of hospital-acquired infections and is often the cause of wound infections following surgery. Each year, around 500,000 patients in hospitals of the United States contract a staphylococcal infection, chiefly by S. aureus.[10] Up to 50,000 deaths each year in the USA are linked with S. aureus infections.[11]
Staphylococcus aureus
Classification and external resources
Specialty
Infectious disease
ICD-9-CM
041.11
[edit on Wikidata]
Contents
[hide]
1 Microbiology
2 Role in health
3 Role in disease
3.1 Skin infections
3.2 Food poisoning
3.3 Bone and joint infections
3.4 Bacteremia
3.5 Biofilms
3.6 Animal infections
4 Virulence factors
4.1 Enzymes
4.2 Toxins
4.3 small RNA
4.4 Strategies for post-transcriptional regulation by 3'untranslated region
4.5 Other immunoevasive strategies
5 Classical diagnosis
5.1 Rapid diagnosis and typing
6 Treatment
6.1 Antibiotic resistance
7 Carriage
8 Infection control
9 Research
10 References
11 Further reading
12 External links
Microbiology[edit]
Gram stain of S. saprophyticus cells which typically occur in clusters: The cell wall readily absorbs the crystal violet stain.
Yellow colonies of S. aureus on a blood agar plate, note regions of clearing around colonies caused by lysis of red cells in the agar (beta hemolysis)
S. aureus (/ˌstæfɪləˈkɒkəs ˈɔːriəs, -loʊ-/,[12][13] Greek σταφυλόκοκκος, "grape-cluster berry", Latin aureus, "golden") is a facultative anaerobic, gram-positive coccal (round) bacterium also known as "golden staph" and "oro staphira". S. aureus is non-motile and does not form spores.[14] In medical literature, the bacterium is often referred to as S. aureus, Staph aureus or Staph A..[15] S. aureus appears as staphylococci (grape-like clusters) when viewed through a microscope, and has large, round, golden-yellow colonies, often with hemolysis, when grown on blood agar plates.[16] S. aureus reproduces asexually by binary fission. Complete separation of the daughter cells is mediated by S. aureus autolysin, and in its absence or targeted inhibition, the daughter cells remain attached to one another and appear as clusters.[17]
S. aureus is catalase-positive (meaning it can produce the enzyme catalase). Catalase converts hydrogen peroxide (H
2O
2) to water and oxygen. Catalase-activity tests are sometimes used to distinguish staphylococci from enterococci and streptococci. Previously, S. aureus was differentiated from other staphylococci by the coagulase test. However, not all S. aureus strains are coagulase-positive[16][18] and incorrect species identification can impact effective treatment and control measures.[19]
Staphylococcus is different from the similarly named and medically relevant genus Streptococcus.
Natural genetic transformation is a reproductive process involving DNA transfer from one bacterium to another through the intervening medium, and the integration of the donor sequence into the recipient genome by homologous recombination. S. aureus was found to be capable of natural genetic transformation, but only at low frequency under the experimental conditions employed.[20] Further studies suggested that the development of competence for natural genetic transformation may be substantially higher under appropriate conditions, yet to be discovered.[21]
Role in health[edit]
In humans, S. aureus is part of the normal microbiota present in the upper respiratory tract,[22] and on skin and in the gut mucosa.[23]
S. aureus, along with similar species that can colonize and act symbiotically but can cause disease if they begin to take over the tissues they have colonized or invade other tissues, have been called "pathobionts".[22]
Role in disease[edit]
Further information: Coagulase-positive staphylococcal infection
This 2005 scanning electron micrograph (SEM) depicts numerous clumps of methicillin-resistant S. aureus (MRSA) bacteria.
While S. aureus usually acts as a commensal bacterium, asymptomatically colonizing about 30% of the human population, it can sometimes cause disease.[5] In particular, S. aureus is one of the most common causes of bacteremia and infective endocarditis. Additionally, it can cause various skin and soft tissue infections,[5] particularly when skin or mucosal barriers have been breached.
S. aureus infections can spread through contact with pus from an infected wound, skin-to-skin contact with an infected person, and contact with objects used by an infected person such as towels, sheets, clothing, or athletic equipment. Joint replacements put a person at particular risk of septic arthritis, staphylococcal endocarditis (infection of the heart valves), and pneumonia.[citation needed]
Diabetics, injection drug users, and individuals with heart conditions, should take extra precautions to avoid coming into contact with staphylococcus aureus, as they are at the highest risk. A couple preventive measures are, washing hands often with soap and making sure to bathe or shower daily.
Staphylococcus aureus can lay dormant in the body for years undetected. Once symptoms begin to show, the host is contagious for another two weeks and the overall illness lasts a few weeks. If untreated though, the disease can be deadly.[24]
Deeply penetrating S. aureus infections can be severe.
Skin infections[edit]
Skin infections are the most common form of S. aureus infection. This can manifest in various ways, including small benign boils, folliculitis, impetigo, cellulitis, and more severe, invasive soft-tissue infections.[9][5]
S. aureus is extremely prevalent in persons with atopic dermatitis. It is mostly found in fertile, active places, including the armpits, hair, and scalp. Large pimples that appear in those areas may exacerbate the infection if lacerated. This can lead to staphylococcal scalded skin syndrome, a severe form of which can be seen in newborns.[25]
The presence of S. aureus in persons with atopic dermatitis is not an indication to treat with oral antibiotics, as evidence has not shown this to give benefit to the patient.[26][27] The relationship between S. aureus and atopic dermatitis is unclear.[26]
Food poisoning[edit]
S. aureus is also responsible for food poisoning. It is capable of generating toxins that produce food poisoning in the human body.[28] Its incubation period lasts one to six hours,[29] with the illness itself lasting anywhere from thirty minutes to three days.[30] Preventative measures one can take to help prevent the spread of the disease include washing hands thoroughly with soap and water before preparing food. Stay away from any food if you are ill, and wear gloves if there are any open wounds on your hands or wrists while preparing food. If storing food for longer than 2 hours, keep the food above 140 degrees Fahrenheit or below 40 degrees Fahrenheit.[31]
Bone and joint infections[edit]
S. aureus is the bacterium that is commonly responsible for all major bone and joint infections. This manifests in one of three forms: osteomyelitis, septic arthritis and infection from a replacement joint surgery.[32][5]
Bacteremia[edit]
S. aureus is a leading cause of bloodstream infections throughout much of the industrialized world.[32] Infection is generally associated with breakages in the skin or mucosal membranes due to surgery, injury, or use of intravascular devices such as catheters, hemodialysis machines, or injected drugs.[5][32] Once the bacteria have entered the bloodstream, they can infect various organs, causing infective endocarditis, septic arthritis, and osteomyelitis.[32] This disease is particularly prevalent and severe in the very young and very old.[5]
Without antibiotic treatment, S. aureus bacteremia has a case fatality rate around 80%.[5] With antibiotic treatment, case fatality rates range from 15% to 50% depending on the age and health of the patient, as well as the antibiotic resistance of the S. aureus strain.[5]
Biofilms[edit]
S. aureus is often found in biofilms formed on medical devices implanted in the body or on human tissue. Remarkable it is commonly found with another pathogen, Candida albicans, forming multispecies biofilms. The latter is suspected to help S. aureus penetrate human tissue.[33] A higher mortality is linked with multispecies biofilms.[34]
Animal infections[edit]
S. aureus can survive on dogs,[35] cats,[36] and horses,[37] and can cause bumblefoot in chickens.[38] Some believe health-care workers' dogs should be considered a significant source of antibiotic-resistant S. aureus, especially in times of outbreak.[35]
S. aureus is one of the causal agents of mastitis in dairy cows. Its large polysaccharide capsule protects the organism from recognition by the cow's immune defenses.[39]
Virulence factors[edit]
Main article: Virulence factor
Enzymes[edit]
S. aureus produces various enzymes such as coagulase (bound and free coagulases) which clots plasma and coats the bacterial cell, probably to prevent phagocytosis. Hyaluronidase (also known as spreading factor) breaks down hyaluronic acid and helps in spreading it. S. aureus also produces deoxyribonuclease, which breaks down the DNA, lipase to digest lipids, staphylokinase to dissolve fibrin and aid in spread, and beta-lactamase for drug resistance.[40]
Toxins[edit]
Depending on the strain, S. aureus is capable of secreting several exotoxins, which can be categorized into three groups. Many of these toxins are associated with specific diseases.[41]
Superantigens
Antigens known as superantigens can induce toxic shock syndrome (TSS). This group includes the toxins TSST-1, and enterotoxin type B, which causes TSS associated with tampon use. Toxic shock syndrome is characterized by fever, erythematous rash, low blood pressure, shock, multiple organ failure, and skin peeling. Lack of antibody to TSST-1 plays a part in the pathogenesis of TSS. Other strains of S. aureus can produce an enterotoxin that is the causative agent of a type of gastroenteritis. This form of gastroenteritis is self-limiting, characterized by vomiting and diarrhea one to six hours after ingestion of the toxin, with recovery in eight to 24 hours. Symptoms include nausea, vomiting, diarrhea, and major abdominal pain.[42][43]
Exfoliative toxins
See also: Exfoliatin
Exfoliative toxins are exotoxins implicated in the disease staphylococcal scalded skin syndrome (SSSS), which occurs most commonly in infants and young children. It also may occur as epidemics in hospital nurseries. The protease activity of the exfoliative toxins causes peeling of the skin observed with SSSS.[43]
Other toxins
Staphylococcal toxins that act on cell membranes include alpha toxin, beta toxin, delta toxin, and several bicomponent toxins. Strains of S. aureus can host phages, such as the prophage Φ-PVL that produces Panton-Valentine leukocidin (PVL), to increase virulence. The bicomponent toxin PVL is associated with severe necrotizing pneumonia in children.[44][45] The genes encoding the components of PVL are encoded on a bacteriophage found in community-associated MRSA strains.[citation needed]
small RNA[edit]
There is a growing list of small RNAs involved in the control of bacterial virulence in S.aureus. For example, RNAIII,[46] SprD,[47] RsaE,[48] SprA1,[49] SSR42,[50] ArtR,[51] SprX and Teg49.[52]
Strategies for post-transcriptional regulation by 3'untranslated region[edit]
It has been shown that many mRNAs in S. aureus carry three prime untranslated regions (3'UTR) longer than 100 nucleotides, which may potentially have a regulatory function.[53]
Further investigation of icaR mRNA (mRNA coding for the repressor of the main expolysaccharidic compound of the bacteria biofilm matrix) demonstrated that the 3'UTR binding to the 5' UTR can interfere with the translation initiation complex and generate a double stranded substrate for RNase III. It was shown that the interaction is between the UCCCCUG motif in the 3'UTR and the Shine-Dalagarno region at the 5'UTR. Deletion of the motif resulted in IcaR repressor accumulation and inhibition of biofilm development.[53] The biofilm formation is the main cause of Staphylococcus implant infections.[54]
Other immunoevasive strategies[edit]
Protein A
Protein A is anchored to staphylococcal peptidoglycan pentaglycine bridges (chains of five glycine residues) by the transpeptidase sortase A.[55] Protein A, an IgG-binding protein, binds to the Fc region of an antibody. In fact, studies involving mutation of genes coding for protein A resulted in a lowered virulence of S. aureus as measured by survival in blood, which has led to speculation that protein A-contributed virulence requires binding of antibody Fc regions.[56]
Protein A in various recombinant forms has been used for decades to bind and purify a wide range of antibodies by immunoaffinity chromatography. Transpeptidases, such as the sortases responsible for anchoring factors like protein A to the staphylococcal peptidoglycan, are being studied in hopes of developing new antibiotics to target MRSA infections.[57]
S. aureus on trypticase soy agar: The strain is producing a yellow pigment staphyloxanthin.
Staphylococcal pigments
Some strains of S. aureus are capable of producing staphyloxanthin — a golden-coloured carotenoid pigment. This pigment acts as a virulence factor, primarily by being a bacterial antioxidant which helps the microbe evade the reactive oxygen species which the host immune system uses to kill pathogens.[58][59]
Mutant strains of S. aureus modified to lack staphyloxanthin are less likely to survive incubation with an oxidizing chemical, such as hydrogen peroxide, than pigmented strains. Mutant colonies are quickly killed when exposed to human neutrophils, while many of the pigmented colonies survive.[58] In mice, the pigmented strains cause lingering abscesses when inoculated into wounds, whereas wounds infected with the unpigmented strains quickly heal.
These tests suggest the Staphylococcus strains use staphyloxanthin as a defence against the normal human immune system. Drugs designed to inhibit the production of staphyloxanthin may weaken the bacterium and renew its susceptibility to antibiotics.[59] In fact, because of similarities in the pathways for biosynthesis of staphyloxanthin and human cholesterol, a drug developed in the context of cholesterol-lowering therapy was shown to block S. aureus pigmentation and disease progression in a mouse infection model.[60]
Classical diagnosis[edit]
Typical gram-positive cocci, in clusters, from a sputum sample, Gram stain
Depending upon the type of infection present, an appropriate specimen is obtained accordingly and sent to the laboratory for definitive identification by using biochemical or enzyme-based tests. A Gram stain is first performed to guide the way, which should show typical gram-positive bacteria, cocci, in clusters. Second, the isolate is cultured on mannitol salt agar, which is a selective medium with 7–9% NaCl that allows S. aureus to grow, producing yellow-colored colonies as a result of mannitol fermentation and subsequent drop in the medium's pH.[citation needed]
Furthermore, for differentiation on the species level, catalase (positive for all Staphylococcus species), coagulase (fibrin clot formation, positive for S. aureus), DNAse (zone of clearance on DNase agar), lipase (a yellow color and rancid odor smell), and phosphatase (a pink color) tests are all done. For staphylococcal food poisoning, phage typing can be performed to determine whether the staphylococci recovered from the food were the source of infection.[citation needed]
Rapid diagnosis and typing[edit]
Your doctor may ask about recent activities and things you have recently eaten, followed by a physical examination in order to review your symptoms. With more severe symptoms, blood tests and stool culture may be in order.[61] Diagnostic microbiology laboratories and reference laboratories are key for identifying outbreaks and new strains of S. aureus. Recent genetic advances have enabled reliable and rapid techniques for the identification and characterization of clinical isolates of S. aureus in real time. These tools support infection control strategies to limit bacterial spread and ensure the appropriate use of antibiotics. Quantitative PCR is increasingly being used to identify outbreaks of infection.[62][63]
When observing the evolvement of S. aureus and its ability to adapt to each modified antibiotic, two basic methods known as “band-based” or “sequence-based” are employed.[64] Keeping these two methods in mind, other methods such as multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), bacteriophage typing, spa locus typing, and SCCmec typing are often conducted more than others.[65] With these methods, it can be determined where strains of MRSA originated and also where they are currently.[66]
With MLST, this technique of typing uses fragments of several housekeeping genes known as aroE, glpF, gmk, pta, tip, and yqiL. These sequences are then assigned a number which give to a string of several numbers that serve as the allelic profile. Although this is a common method, a limitation about this method is the maintenance of the microarray which detects newly allelic profiles, making it a costly and time-consuming experiment.[64]
With PFGE, a method which is still very much used dating back to its first success in 1980s, remains capable of helping differentiate MRSA isolates.[66] To accomplish this, the technique uses multiple gel electrophoresis, along with a voltage gradient to display clear resolutions of molecules. The S. aureus fragments then transition down the gel, producing specific band patters that are later compared with other isolates in hopes of identifying related strains. Limitations of the method include practical difficulties with uniform band patterns and PFGE sensitivity as a whole.
Spa locus typing is also considered a popular technique that uses a single locus zone in a polymorphic region of S. aureus to distinguish any form of mutations.[66] Although this technique is often inexpensive and less time-consuming, the chance of losing discriminatory power makes it hard to differentiate between MLST CCs exemplifies a crucial limitation.
Treatment[edit]
The treatment of choice for S. aureus infection is penicillin. An antibiotic derived from some Penicillium fungal species, penicillin inhibits the formation of peptidoglycan cross-linkages that provide the rigidity and strength in a bacterial cell wall. The four-membered β-lactam ring of penicillin is bound to enzyme DD-transpeptidase, an enzyme that when functional, cross-links chains of peptidoglycan that form bacterial cell walls. The binding of β-lactam to DD-transpeptidase inhibits the enzyme’s functionality and it can no longer catalyze the formation of the cross-links. As a result, cell wall formation and degradation are imbalanced, thus resulting in cell death. In most countries, however, penicillin resistance is extremely common, and first-line therapy is most commonly a penicillinase-resistant β-lactam antibiotic (for example, oxacillin or flucloxacillin, both of which have the same mechanism of action as penicillin). Combination therapy with gentamicin may be used to treat serious infections, such as endocarditis,[67][68] but its use is controversial because of the high risk of damage to the kidneys.[69] The duration of treatment depends on the site of infection and on severity.
Antibiotic resistance in S. aureus was uncommon when penicillin was first introduced in 1943. Indeed, the original Petri dish on which Alexander Fleming of Imperial College London observed the antibacterial activity of the Penicillium fungus was growing a culture of S. aureus. By 1950, 40% of hospital S. aureus isolates were penicillin-resistant; by 1960, this had risen to 80%.[70]
MRSA, often pronounced /ˈmɜːrsə/ or /ɛm ɑːr ɛs eɪ/, is one of a number of greatly feared strains of S. aureus which have become resistant to most β-lactam antibiotics. For this reason, vancomycin, a glycopeptide antibiotic, is commonly used to combat MRSA. Vancomycin inhibits the synthesis of peptidoglycan, but unlike β-lactam antibiotics, glycopeptide antibiotics target and bind to amino acids in the cell wall, preventing peptidoglycan cross-linkages from forming. MRSA strains are most often found associated with institutions such as hospitals, but are becoming increasingly prevalent in community-acquired infections.
Wikinews has related news: Supergerm deaths soar, surpass AIDS in the United States
Minor skin infections can be treated with triple antibiotic ointment.[71]
Antibiotic resistance[edit]
Bacterial cells of S. aureus, which is one of the causal agents of mastitis in dairy cows: Its large capsule protects the organism from attack by the cow's immunological defenses.
Staphylococcal resistance to penicillin is mediated by penicillinase (a form of β-lactamase) production: an enzyme that cleaves the β-lactam ring of the penicillin molecule, rendering the antibiotic ineffective. Penicillinase-resistant β-lactam antibiotics, such as methicillin, nafcillin, oxacillin, cloxacillin, dicloxacillin, and flucloxacillin, are able to resist degradation by staphylococcal penicillinase.
Resistance to methicillin is mediated via the mec operon, part of the staphylococcal cassette chromosome mec (SCCmec). Resistance is conferred by the mecA gene, which codes for an altered penicillin-binding protein (PBP2a or PBP2') that has a lower affinity for binding β-lactams (penicillins, cephalosporins, and carbapenems). This allows for resistance to all β-lactam antibiotics, and obviates their clinical use during MRSA infections. As such, the glycopeptide vancomycin is often deployed against MRSA.
Aminoglycoside antibiotics, such as kanamycin, gentamicin, streptomycin, etc., were once effective against staphylococcal infections until strains evolved mechanisms to inhibit the aminoglycosides' action, which occurs via protonated amine and/or hydroxyl interactions with the ribosomal RNA of the bacterial 30S ribosomal subunit.[72] Three main mechanisms of aminoglycoside resistance mechanisms are currently and widely accepted: aminoglycoside modifying enzymes, ribosomal mutations, and active efflux of the drug out of the bacteria.
Aminoglycoside-modifying enzymes inactivate the aminoglycoside by covalently attaching either a phosphate, nucleotide, or acetyl moiety to either the amine or the alcohol key functional group (or both groups) of the antibiotic. This changes the charge or sterically hinders the antibiotic, decreasing its ribosomal binding affinity. In S. aureus, the best-characterized aminoglycoside-modifying enzyme is aminoglycoside adenylyltransferase 4' IA (ANT(4')IA). This enzyme has been solved by X-ray crystallography.[73] The enzyme is able to attach an adenyl moiety to the 4' hydroxyl group of many aminoglycosides, including kamamycin and gentamicin.
Glycopeptide resistance is mediated by acquisition of the vanA gene, which originates from the enterococci and codes for an enzyme that produces an alternative peptidoglycan to which vancomycin will not bind.
Today, S. aureus has become resistant to many commonly used antibiotics. In the UK, only 2% of all S. aureus isolates are sensitive to penicillin, with a similar picture in the rest of the world. The β-lactamase-resistant penicillins (methicillin, oxacillin, cloxacillin, and flucloxacillin) were developed to treat penicillin-resistant S. aureus, and are still used as first-line treatment. Methicillin was the first antibiotic in this class to be used (it was introduced in 1959), but, only two years later, the first case of MRSA was reported in England.[74]
Despite this, MRSA generally remained an uncommon finding, even in hospital settings, until the 1990s, when the MRSA prevalence in hospitals exploded, and it is now endemic.[75]
MRSA infections in both the hospital and community setting are commonly treated with non-β-lactam antibiotics, such as clindamycin (a lincosamine) and co-trimoxazole (also commonly known as trimethoprim/sulfamethoxazole). Resistance to these antibiotics has also led to the use of new, broad-spectrum anti-gram-positive antibiotics, such as linezolid, because of its availability as an oral drug. First-line treatment for serious invasive infections due to MRSA is currently glycopeptide antibiotics (vancomycin and teicoplanin). A number of problems with these antibiotics occur, such as the need for intravenous administration (no oral preparation is available), toxicity, and the need to monitor drug levels regularly by blood tests. Also, glycopeptide antibiotics do not penetrate very well into infected tissues (this is a particular concern with infections of the brain and meninges and in endocarditis). Glycopeptides must not be used to treat methicillin-sensitive S. aureus (MSSA), as outcomes are inferior.[76]
Because of the high level of resistance to penicillins and because of the potential for MRSA to develop resistance to vancomycin, the U.S. Centers for Disease Control and Prevention has published guidelines for the appropriate use of vancomycin. In situations where the incidence of MRSA infections is known to be high, the attending physician may choose to use a glycopeptide antibiotic until the identity of the infecting organism is known. After the infection is confirmed to be due to a methicillin-susceptible strain of S. aureus, treatment can be changed to flucloxacillin or even penicillin], as appropriate.
Vancomycin-resistant S. aureus (VRSA) is a strain of S. aureus that has become resistant to the glycopeptides. The first case of vancomycin-intermediate S. aureus (VISA) was reported in Japan in 1996;[77] but the first case of S. aureus truly resistant to glycopeptide antibiotics was only reported in 2002.[78] Three cases of VRSA infection had been reported in the United States as of 2005.[79]
Carriage[edit]
About 33% of the U.S. population are carriers of S. aureus and about 2% carry MRSA.[80]
The carriage of S. aureus is an important source of hospital-acquired infection (also called nosocomial) and community-acquired MRSA. Although S. aureus can be present on the skin of the host, a large proportion of its carriage is through the anterior nares of the nasal passages[4] and can further be present in the ears.[81] The ability of the nasal passages to harbour S. aureus results from a combination of a weakened or defective host immunity and the bacterium's ability to evade host innate immunity.[82] Nasal carriage is also implicated in the occurrence of staph infections.[83]
Infection control[edit]
Spread of S. aureus (including MRSA) generally is through human-to-human contact, although recently some veterinarians have discovered the infection can be spread through pets,[84] with environmental contamination thought to play a relatively unimportant part. Emphasis on basic hand washing techniques are, therefore, effective in preventing its transmission. The use of disposable aprons and gloves by staff reduces skin-to-skin contact, so further reduces the risk of transmission.
Recently, myriad cases of S. aureus have been reported in hospitals across America. Transmission of the pathogen is facilitated in medical settings where healthcare worker hygiene is insufficient. S. aureus is an incredibly hardy bacterium, as was shown in a study where it survived on polyester for just under three months;[85] polyester is the main material used in hospital privacy curtains.
The bacteria are transported on the hands of healthcare workers, who may pick them up from a seemingly healthy patient carrying a benign or commensal strain of S. aureus, and then pass it on to the next patient being treated. Introduction of the bacteria into the bloodstream can lead to various complications, including endocarditis, meningitis, and, if it is widespread, sepsis.
Ethanol has proven to be an effective topical sanitizer against MRSA. Quaternary ammonium can be used in conjunction with ethanol to increase the duration of the sanitizing action. The prevention of nosocomial infections involves routine and terminal cleaning. Nonflammable alcohol vapor in CO
2 NAV-CO2 systems have an advantage, as they do not attack metals or plastics used in medical environments, and do not contribute to antibacterial resistance.
An important and previously unrecognized means of community-associated MRSA colonization and transmission is during sexual contact.[86]
S. aureus is killed in one minute at 78 °C and in ten minutes at 64 °C.[87]
Top common bacterium in each industry
Catering industry
Vibrio parahaemolyticus, S. aureus, Bacillus cereus
Medical industry
Escherichia coli, S. aureus, Pseudomonas aeruginosa[88]
Research[edit]
As of 2015, no approved vaccine exists against S. aureus. Early clinical trials have been conducted for several vaccines candidates such as Nabi’s StaphVax and PentaStaph, Intercell’s / Merck’s V710, VRi’s SA75, and others.[89]
While some of these vaccines candidates have shown immune responses, other aggravated an infection by S. aureus. To date, none of these candidates provides protection against a S. aureus infection. The development of Nabi’s StaphVax was stopped in 2005 after phase III trials failed.[90] Intercell’s first V710 vaccine variant was terminated during phase II/III after higher mortality and morbidity were observed among patients who developed S. aureus infection.[91]
Nabi's enhanced S. aureus vaccines candidate PentaStaph was sold in 2011 to GlaxoSmithKline Biologicals S.A.[92] The current status of PentaStaph is unclear. A WHO document indicates that PentaStaph is failed in phase III trial stage.[93]
In 2010, GlaxoSmithKline started a phase 1 blind study to evaluate its GSK2392103A vaccine.[94] As of 2016, this vaccine is no longer under active development.[95]
Pfizer's S. aureus four-antigen vaccine SA4Ag was granted fast track designation by the U.S. Food and Drug Administration in February 2014.[96] In 2015, Pfizer has commenced a phase 2b trial regarding the SA4Ag vaccine.[97] Phase 1 results published in February 2017 showed a very robust and secure immunogenicity of SA4Ag.[98]
Novartis Vaccines and Diagnostics, a former division of Novartis and now part of GlaxoSmithKline, published in 2015 promising pre-clinical results of their four-component Staphylococcus aureus vaccine, 4C-staph.[99]
References[edit]
Jump up ^ Masalha M; et al. (2001). "Analysis of Transcription of the Staphylococcus Aureus Aerobic Class Ib and Anaerobic Class III Ribonucleotide Reductase Genes in Response to Oxygen". Journal of Bacteriology. 183 (24): 7260–7272. PMC 95576  . PMID 11717286. doi:10.1128/jb.183.24.7260-7272.2001. CS1 maint: Explicit use of et al. (link)
Jump up ^ Ogston A (1984). ""On Abscesses". Classics in Infectious Diseases". Rev Infect Dis. 6 (1): 122–28. PMID 6369479. doi:10.1093/clinids/6.1.122.
Jump up ^ "Whonamedit - dictionary of medical eponyms". www.whonamedit.com.
^ Jump up to: a b c Kluytmans J, van Belkum A, Verbrugh H (July 1997). "Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks". Clin. Microbiol. Rev. 10 (3): 505–20. PMC 172932  . PMID 9227864.
^ Jump up to: a b c d e f g h i Tong SY; Davis JS; Eichenberger E; Holland TL; Fowler VG (July 2015). "Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management". Clinical Microbiology Reviews. 28 (3): 603–661. PMC 4451395  . PMID 26016486. doi:10.1128/CMR.00134-14.
Jump up ^ Cole, A. M.; Tahk, S.; Oren, A.; Yoshioka, D.; Kim, Y. H.; Park, A.; Ganz, T (November 2001). "Determinants of Staphylococcus aureus nasal carriage". Clin Diagn Lab Immunol. 8 (6): 1064–9. PMC 96227  . PMID 11687441. doi:10.1128/CDLI.8.6.1064-1069.2001.
Jump up ^ Senok, Abiola C; Verstraelen, Hans; Temmerman, Marleen; Botta, Giuseppe A; Senok, Abiola C (2009). "Probiotics for the treatment of bacterial vaginosis". Cochrane Database Syst Rev (4): CD006289. PMID 19821358. doi:10.1002/14651858.CD006289.pub2.
Jump up ^ Hoffman, Barbara (2012). Williams gynecology, 2nd edition. New York: McGraw-Hill Medical. p. 65. ISBN 0071716726.
^ Jump up to: a b "Staphylococcal Infections". MedlinePlus [Internet]. Bethesda, MD: National Library of Medicine, USA. Skin infections are the most common. They can look like pimples or boils.
Jump up ^ Bowersox, John (27 May 1999). "Experimental Staph Vaccine Broadly Protective in Animal Studies". NIH. Archived from the original on 5 May 2007. Retrieved 28 July 2007.
Jump up ^ Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME. "Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue". Microbiology. 161: 168–81. PMC 4274785  . PMID 25332378. doi:10.1099/mic.0.083485-0. CS1 maint: Multiple names: authors list (link)
Jump up ^ "Staphylococcus". Dictionary.com Unabridged. Random House. "aureus". Dictionary.com Unabridged. Random House.
Jump up ^ "staphylococcus - definition of staphylococcus in English from the Oxford dictionary". OxfordDictionaries.com. Retrieved 2016-01-20. "aureus - definition of aureus in English from the Oxford dictionary". OxfordDictionaries.com. Retrieved 2016-01-20.
Jump up ^ "PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES." Staphylococcus cells have a diameter of 0.7-1.2 um. Staphylococcus Aureus. Public Health Agency of Canada, 2011. Web
Jump up ^ "Canadian Centre for Occupational Health and Safety". Retrieved 8 April 2016.
^ Jump up to: a b Ryan, KJ; Ray, CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 0-8385-8529-9.
Jump up ^ Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG, Kates SL, Daiss JL, Schwarz EM (2014). "Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.". Journal of Orthopedic Research. 32 (10): 1389–96. doi:10.1002/jor.22672.
Jump up ^ PreTest, Surgery, 12th ed., p.88
Jump up ^ Matthews KR, Roberson J, Gillespie BE, Luther DA, Oliver SP (1997). "Identification and Differentiation of Coagulase-Negative Staphylococcus aureus by Polymerase Chain Reaction". Journal of Food Protection. 60 (6): 686–8.
Jump up ^ Morikawa K, Takemura AJ, Inose Y, Tsai M, Nguyen Thi le T, Ohta T, Msadek T (2012). "Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus". PLoS Pathog. 8 (11): e1003003. PMC 3486894  . PMID 23133387. doi:10.1371/journal.ppat.1003003.
Jump up ^ Fagerlund A, Granum PE, Håvarstein LS (2014). "Staphylococcus aureus competence genes: mapping of the SigH, ComK1 and ComK2 regulons by transcriptome sequencing". Mol. Microbiol. 94 (3): 557–79. PMID 25155269. doi:10.1111/mmi.12767.
^ Jump up to: a b Schenck, LP; Surette, MG; Bowdish, DM (November 2016). "Composition and immunological significance of the upper respiratory tract microbiota.". FEBS Letters. 590 (21): 3705–3720. PMID 27730630. doi:10.1002/1873-3468.12455.
Jump up ^ Wollina, U (2017). "Microbiome in atopic dermatitis.". Clinical, Cosmetic and Investigational Dermatology. 10: 51–56. PMC 5327846  . PMID 28260936. doi:10.2147/CCID.S130013.
Jump up ^ "Staphylococcus aureus in Healthcare Settings | HAI | CDC". www.cdc.gov. Retrieved 2017-04-19.
Jump up ^ Curran JP, Al-Salihi FL (1980). "Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type". Pediatrics. 66 (2): 285–90. PMID 6447271.
^ Jump up to: a b American Academy of Dermatology (February 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Academy of Dermatology, retrieved 5 December 2013
Jump up ^ Birnie, A. J.; Bath-Hextall, F. J.; Ravenscroft, J. C.; Williams, H. C. (2008). Birnie, Andrew J, ed. "Interventions to reduce Staphylococcus aureus in the management of atopic eczema". The Cochrane database of systematic reviews (3): CD003871. PMID 18646096. doi:10.1002/14651858.CD003871.pub2.
Jump up ^ "Staphylococcal Food Poisoning". cdc.gov. hhs.gov. 4 October 2016. Retrieved 23 October 2016.
Jump up ^ "Staphylococcus." Foodsafety.gov, U.S. Department of Health and Human Services, https://www.foodsafety.gov/poisoning/causes/bacteriaviruses/staphylococcus/.
Jump up ^ "Staphylococcal Food Poisoning." Food Safety, Centers for Disease Control and Prevention, 4 Oct. 2016, https://www.cdc.gov/foodsafety/diseases/staphylococcal.html.
Jump up ^ Woodson, James. "Centers for disease control and prevention". Food Safety. Retrieved 24 October 2017.
^ Jump up to: a b c d Rasmussen RV; Fowler VG; Skov R; Bruun NE (January 2011). "Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA". Future Microbiology. 6 (1): 43–56. PMC 3031962  . PMID 21162635. doi:10.2217/fmb.10.155.
Jump up ^ Schlecht, Lisa Marie; Freiberg, Jeffrey A.; Hänsch, Gertrud M.; Peters, Brian M.; Shirtliff, Mark E.; Krom, Bastiaan P.; Filler, Scott G.; Jabra-Rizk, Mary Ann (2015). "Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue". Microbiology. 161 (Pt 1): 168–81. PMC 4274785  . PMID 25332378. doi:10.1099/mic.0.083485-0.
Jump up ^ Zago, Chaiene Evelin; Silva, Sónia; Sanitá, Paula Volpato; Barbugli, Paula Aboud; Dias, Carla Maria Improta; Lordello, Virgínia Barreto; Vergani, Carlos Eduardo (2015). "Dynamics of Biofilm Formation and the Interaction between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA)". PLoS ONE. 10 (4): e0123206. PMC 4395328  . PMID 25875834. doi:10.1371/journal.pone.0123206.
^ Jump up to: a b Boost MV, O'Donoghue MM, James A (2008). "Prevalence of Staphylococcus aureus carriage among dogs and their owners". Epidemiol. Infect. 136 (7): 953–964. PMC 2870875  . PMID 17678561. doi:10.1017/S0950268807009326.
Jump up ^ Hanselman BA, Kruth SA, Rousseau J, Weese JS (2009). "Coagulase positive staphylococcal colonization of humans and their household pets". Can. Vet. 50 (9): 954–8. PMC 2726022  . PMID 19949556.
Jump up ^ Burton S, Reid-Smith R, McClure JT, Weese JS (2008). "Staphylococcus aureus colonization in healthy horses in Atlantic Canada". Can. Vet. J. 49 (8): 797–799. PMC 2465786  . PMID 18978975.
Jump up ^ "Staphylococcosis, Staphylococcal Arthritis, Bumble Foot". The Poultry Site. Retrieved 2013-10-22.
Jump up ^ Cenci-Goga BT, Karama M, Rossitto PV, Morgante RA, Cullor JS (September 2003). "Enterotoxin production by Staphylococcus aureus isolated from mastitic cows". Journal of food protection. 66 (9): 1693–6. PMID 14503727.
Jump up ^ Medical Laboratory Manual For Tropical Countries vol two
Jump up ^ Dinges MM, Orwin PM, Schlievert PM (January 2000). "Exotoxins of Staphylococcus aureus". Clin. Microbiol. Rev. 13 (1): 16–34, table of contents. PMC 88931  . PMID 10627489. doi:10.1128/cmr.13.1.16-34.2000.
Jump up ^ Jarraud S, Peyrat MA, Lim A, et al. (January 2001). "egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus". J. Immunol. 166 (1): 669–77. PMID 11123352. doi:10.4049/jimmunol.166.1.669.
^ Jump up to: a b Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C (April 2003). "Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens". J. Clin. Microbiol. 41 (4): 1434–9. PMC 153929  . PMID 12682126. doi:10.1128/jcm.41.4.1434-1439.2003.
Jump up ^ Lina G, Piémont Y, Godail-Gamot F, et al. (November 1999). "Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia". Clin. Infect. Dis. 29 (5): 1128–32. PMID 10524952. doi:10.1086/313461.
Jump up ^ Gillet Y, Issartel B, Vanhems P, et al. (March 2002). "Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients". Lancet. 359 (9308): 753–9. PMID 11888586. doi:10.1016/S0140-6736(02)07877-7. As PDF
Jump up ^ Chevalier, Clément; Boisset, Sandrine; Romilly, Cédric; Masquida, Benoit; Fechter, Pierre; Geissmann, Thomas; Vandenesch, François; Romby, Pascale (2010-03-12). "Staphylococcus aureus RNAIII Binds to Two Distant Regions of coa mRNA to Arrest Translation and Promote mRNA Degradation". PLOS Pathogens. 6 (3): e1000809. ISSN 1553-7374. PMC 2837412  . PMID 20300607. doi:10.1371/journal.ppat.1000809.
Jump up ^ Chabelskaya, Svetlana; Gaillot, Olivier; Felden, Brice (2010-06-03). "A Staphylococcus aureus Small RNA Is Required for Bacterial Virulence and Regulates the Expression of an Immune-Evasion Molecule". PLOS Pathogens. 6 (6): e1000927. ISSN 1553-7374. PMC 2880579  . PMID 20532214. doi:10.1371/journal.ppat.1000927.
Jump up ^ Bohn, C.; Rigoulay, C.; Chabelskaya, S.; Sharma, C. M.; Marchais, A.; Skorski, P.; Borezee-Durant, E.; Barbet, R.; Jacquet, E. (2010-10-01). "Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism". Nucleic Acids Research. 38 (19): 6620–6636. ISSN 0305-1048. PMC 2965222  . PMID 20511587. doi:10.1093/nar/gkq462.
Jump up ^ Sayed, Nour; Jousselin, Ambre; Felden, Brice. "A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide". Nature Structural & Molecular Biology. 19 (1): 105–112. doi:10.1038/nsmb.2193.
Jump up ^ Morrison, John M.; Miller, Eric W.; Benson, Meredith A.; Alonzo, Francis; Yoong, Pauline; Torres, Victor J.; Hinrichs, Steven H.; Dunman, Paul M. (2012-06-01). "Characterization of SSR42, a Novel Virulence Factor Regulatory RNA That Contributes to the Pathogenesis of a Staphylococcus aureus USA300 Representative". Journal of Bacteriology. 194 (11): 2924–2938. ISSN 0021-9193. PMC 3370614  . PMID 22493015. doi:10.1128/JB.06708-11.
Jump up ^ Xue, Ting; Zhang, Xu; Sun, Haipeng; Sun, Baolin (2013-08-18). "ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5′ UTR of sarT mRNA". Medical Microbiology and Immunology. 203 (1): 1–12. ISSN 0300-8584. doi:10.1007/s00430-013-0307-0.
Jump up ^ Kim, Samin; Reyes, Dindo; Beaume, Marie; Francois, Patrice; Cheung, Ambrose (2014-10-01). "Contribution of teg49 small RNA in the 5' upstream transcriptional region of sarA to virulence in Staphylococcus aureus". Infection and Immunity. 82 (10): 4369–4379. ISSN 1098-5522. PMC 4187880  . PMID 25092913. doi:10.1128/IAI.02002-14.
^ Jump up to: a b Ruiz de los Mozos, I; Vergara-Irigaray, M; Segura, V; Villanueva, M; Bitarte, N; Saramago, M; Domingues, S; Arraiano, CM; Fechter, P; Romby, P; Valle, J; Solano, C; Lasa, I; Toledo-Arana, A (2013). "Base pairing interaction between 5'- and 3'-UTRs controls icaR mRNA translation in Staphylococcus aureus.". PLOS Genetics. 9 (12): e1004001. PMC 3868564  . PMID 24367275. doi:10.1371/journal.pgen.1004001.
Jump up ^ Arciola, Carla Renata; Campoccia, Davide; Speziale, Pietro; Montanaro, Lucio; Costerton, John William. "Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials". Biomaterials. 33 (26): 5967–5982. doi:10.1016/j.biomaterials.2012.05.031.
Jump up ^ Schneewind O, Fowler A, Faull KF (April 1995). "Structure of the cell wall anchor of surface proteins in Staphylococcus aureus". Science. 268 (5207): 103–6. PMID 7701329. doi:10.1126/science.7701329.
Jump up ^ Patel AH, Nowlan P, Weavers ED, Foster T (December 1987). "Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement". Infect. Immun. 55 (12): 3103–10. PMC 260034  . PMID 3679545.
Jump up ^ Zhu J, Lu C, Standland M, et al. (February 2008). "Single mutation on the surface of Staphylococcus aureus Sortase A can disrupt its dimerization". Biochemistry. 47 (6): 1667–74. PMID 18193895. doi:10.1021/bi7014597.
^ Jump up to: a b Clauditz A, Resch A, Wieland KP, Peschel A, Götz F (August 2006). "Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress". Infection and immunity. 74 (8): 4950–3. PMC 1539600  . PMID 16861688. doi:10.1128/IAI.00204-06.
^ Jump up to: a b Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V (2005). "Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity". J Exp Med. 202 (2): 209–15. PMC 2213009  . PMID 16009720. doi:10.1084/jem.20050846.
Jump up ^ Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E (2008). "A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence". Science. 319 (5868): 391–94. PMC 2747771  . PMID 18276850. doi:10.1126/science.1153018.
Jump up ^ Krause, Lydia. "Staphylococcus Aureus food poisoning". healthline. Retrieved 24 October 2017.
Jump up ^ Francois P, Schrenzel J (2008). "Rapid Diagnosis and Typing of Staphylococcus aureus". Staphylococcus: Molecular Genetics. Caister Academic Press. ISBN 978-1-904455-29-5.
Jump up ^ Mackay IM, ed. (2007). Real-Time PCR in Microbiology: From Diagnosis to Characterization. Caister Academic Press. ISBN 978-1-904455-18-9.
^ Jump up to: a b Deurenberg RH, Stobberingh EE (Dec 2008). "The evolution of Staphylococcus aureus". Infection, Genetics and Evolution. 8 (6): 747–763. PMID 18718557. doi:10.1016/j.meegid.2008.07.007.
Jump up ^ Sousa MD, Conceicao T, Simas C, Lencastre HD (Oct 2005). "Comparison of Genetic Backgrounds of Methicillin-Resistant and -Susceptible Staphylococcus aureus Isolates from Portuguese Hospitals and the Community". Journal of Clinical Microbiology. 43 (10): 5150–5157. PMC 1248511  . PMID 16207977. doi:10.1128/JCM.43.10.5150-5157.2005.
^ Jump up to: a b c Kim J (2009). "Understanding the Evolution of Methicillin-Resistant Staphylococcus aureus". Clinical Microbiology Newsletter. 31 (3): 17–23. doi:10.1016/j.clinmicnews.2009.01.002.
Jump up ^ Korzeniowski O, Sande MA (1982). "Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study". Ann Intern Med. 97 (4): 496–503. PMID 6751182. doi:10.7326/0003-4819-97-4-496.
Jump up ^ Bayer AS, Bolger AF, Taubert KA, et al. (1998). "Diagnosis and management of infective endocarditis and its complications". Circulation. 98 (25): 2936–48. PMID 9860802. doi:10.1161/01.CIR.98.25.2936.
Jump up ^ Cosgrove SE, Vigliani GA, Campion M, et al. (2009). "Initial low‐dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic". Clin Infect Dis. 48 (6): 713–721. PMID 19207079. doi:10.1086/597031.
Jump up ^ Chambers HF (2001). "The changing epidemiology of Staphylococcus aureus?". Emerg Infect Dis. 7 (2): 178–82. PMC 2631711  . PMID 11294701. doi:10.3201/eid0702.010204.
Jump up ^ Bonomo, Robert A.; Zile, Peter S. Van; Li, Qing; Shermock, Kenneth M.; McCormick, William G.; Kohut, Bruce (2007-10-01). "Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective". Expert Review of Anti-infective Therapy. 5 (5): 773–782. ISSN 1478-7210. doi:10.1586/14787210.5.5.773.
Jump up ^ Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (September 2000). "Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics". Nature. 407 (6802): 340–8. PMID 11014183. doi:10.1038/35030019.
Jump up ^ Sakon J, Liao HH, Kanikula AM, Benning MM, Rayment I, Holden HM (November 1993). "Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution". Biochemistry. 32 (45): 11977–84. PMID 8218273. doi:10.1021/bi00096a006.
Jump up ^ Jevons MP (1961). "Celbenin-resistant staphylococci". BMJ. 1 (5219): 124–5. doi:10.1136/bmj.1.5219.124-a.
Jump up ^ Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, Livermore DM, Cookson BD (2001). "Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)". J Antimicrob Chemother. 48 (1): 143–4. PMID 11418528. doi:10.1093/jac/48.1.143.
Jump up ^ [verification needed] Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002). "Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus". Arch Intern Med. 162 (19): 22293–5. PMID 12390067. doi:10.1001/archinte.162.19.2229.
Jump up ^ Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997). "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility" (PDF). J Antimicrob Chemother. 40 (1): 135–6. PMID 9249217. doi:10.1093/jac/40.1.135.
Jump up ^ Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK (2003). "Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene". N Engl J Med. 348 (14): 1342–7. PMID 12672861. doi:10.1056/NEJMoa025025.
Jump up ^ Menichetti F (2005). "Current and emerging serious gram-positive infections". Clin Microbiol Infect. 11 (Suppl 3): 22–8. PMID 15811021. doi:10.1111/j.1469-0691.2005.01138.x.
Jump up ^ "General Information: Community acquired MRSA". CDC. March 25, 2016.
Jump up ^ Campos, A.; Arias, A.; Betancor, L.; Rodríguez, C.; Hernández, A. M.; López Aguado, D.; Sierra, A. (1998-07-01). "Study of common aerobic flora of human cerumen". The Journal of Laryngology and Otology. 112 (7): 613–616. ISSN 0022-2151. PMID 9775288.
Jump up ^ Quinn, G. A.; Cole, A. M (September 2007). "Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium". Immunology. 122 (1): 80–9. PMC 2265977  . PMID 17472720. doi:10.1111/j.1365-2567.2007.02615.x.
Jump up ^ Wertheim, Heiman F. L.; Melles, Damian C.; Vos, Margreet C.; van Leeuwen, Willem; van Belkum, Alex; Verbrugh, Henri A.; Nouwen, Jan L. (2005-12-01). "The role of nasal carriage in Staphylococcus aureus infections". The Lancet. Infectious Diseases. 5 (12): 751–762. ISSN 1473-3099. PMID 16310147. doi:10.1016/S1473-3099(05)70295-4.
Jump up ^ Sing A, Tuschak C, Hoermansdorfer S (March 2008). "Methicillin-Resistant Staphylococcus aureus in a Family and Its Pet Cat". N Engl J Med. 358 (11): 1200–1. PMID 18337614. doi:10.1056/NEJMc0706805.
Jump up ^ Neely AN, Maley MP (February 2000). "Survival of enterococci and staphylococci on hospital fabrics and plastic". J. Clin. Microbiol. 38 (2): 724–6. PMC 86187  . PMID 10655374.
Jump up ^ Cook H, Furuya E, Larson E, Vasquez G, Lowy F (2007). "Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus". Clin Infect Dis. 44 (3): 410–3. PMID 17205449. doi:10.1086/510681.
Jump up ^ Shafiei Y, Razavilar V, Javadi A (2011). "Thermal Death Time of Staphylococcus Aureus (PTCC=29213) and Staphylococcus Epidermidis (PTCC=1435) in Distilled Water" (PDF). Australian Journal of Basic and Applied Sciences. 5 (11): 1551–4.
Jump up ^ "Food standard agency".
Jump up ^ "A Shot Against MRSA?" (PDF). Resources for the Future. 2009-04-20. Retrieved 2015-10-07.
Jump up ^ "Strengthening the immune system as an antimicrobial strategy against Staphylococcus aureus infections" (PDF). FORMATEX RESEARCH CENTER. 2013-12-11. Retrieved 2015-10-07.
Jump up ^ "Intercell, Merck terminate V710 Phase II/III trial against S. aureus infection". Merck & Co. 2011-06-08. Retrieved 2015-10-07.
Jump up ^ "Nabi Biopharmaceuticals Completes Final PentaStaph(TM) Milestone". GLOBE NEWSWIRE. 2011-04-27. Retrieved 2015-10-07.
Jump up ^ "Vaccines to prevent antibiotic‐resistant Staphylococcus aureus (MRSA)infections" (PDF). University of Chicago. Retrieved 2017-05-11.
Jump up ^ "A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults". ClinicalTrials.gov. 2010-07-01. Retrieved 2015-10-07.
Jump up ^ "Status of vaccine research and development of vaccines for Staphylococcus aureus" (PDF). ELSEVIER. 2016-04-19. Retrieved 2016-10-10.
Jump up ^ "Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery". Pfizer Inc. 2015-07-07. Retrieved 2016-02-24.
Jump up ^ "Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Posterior Instrumented Lumbar Spinal Fusion Procedure (STRIVE)". ClinicalTrials.gov. 2015-03-09. Retrieved 2015-10-07.
Jump up ^ Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, Eiden J, Gruber WC, Jansen KU, Anderson AS, Gurtman A (2017-02-22). "SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies". Vaccine. 35 (8): 1132–1139. PMID 28143674. doi:10.1016/j.vaccine.2017.01.024. CS1 maint: Multiple names: authors list (link)
Jump up ^ Torre A, Bacconi M, Sammicheli C, Galletti B, Laera D, Fontana MR, Grandi G, De Gregorio E, Bagnoli F, Nuti S, Bertholet S, Bensi G (2015-05-26). "Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice". Infect Immun. 83 (8): 3157–63. PMC 4496606  . PMID 26015481. doi:10.1128/IAI.00258-15. CS1 maint: Multiple names: authors list (link)
Further reading[edit]
Loskill, Peter; Pereira, Pedro M.; Jung, Philipp; Bischoff, Markus; Herrmann, Mathias; Pinho, Mariana G.; Jacobs, Karin (2 September 2014). "Reduction of the Peptidoglycan Crosslinking Causes a Decrease in Stiffness of the Staphylococcus aureus Cell Envelope". Biophysical Journal. 107 (5): 1082–1089. PMC 4156677  . PMID 25185544. doi:10.1016/j.bpj.2014.07.029. Retrieved 14 November 2014.
External links[edit]
Wikimedia Commons has media related to Staphylococcus aureus.
Wikispecies has information related to: Staphylococcus aureus
StopMRSANow.org — Discusses how to prevent the spread of MRSA
TheMRSA.com — Understand what the MRSA infection is all about.
"Staphylococcus aureus". NCBI Taxonomy Browser. 1280.
Packham, Christopher (March 16, 2015). "Successful in vivo test of breakthrough Staphylococcus aureus vaccine". Medical Press. Archived from the original on September 19, 2012. Retrieved 18 March 2015.
Type strain of Staphylococcus aureus at BacDive - the Bacterial Diversity Metadatabase
[hide]
v
t
e
Firmicutes (low-G+C) Infectious diseases
Bacterial diseases: G+
primarily A00–A79, 001–041, 080–109
Bacilli
Lactobacillales
(Cat-)
Streptococcus
α
optochin susceptible
S. pneumoniae
Pneumococcal infection
optochin resistant
Viridans streptococci: S. mitis
S. mutans
S. oralis
S. sanguinis
S. sobrinus
milleri group
β
A
bacitracin susceptible: S. pyogenes
Group A streptococcal infection
Streptococcal pharyngitis
Scarlet fever
Erysipelas
Rheumatic fever
B
bacitracin resistant, CAMP test+: S. agalactiae
Group B streptococcal infection
ungrouped
Streptococcus iniae
Cutaneous Streptococcus iniae infection
γ
D
BEA+: Streptococcus bovis
Enterococcus
BEA+: Enterococcus faecalis
Urinary tract infection
Enterococcus faecium
Bacillales
(Cat+)
Staphylococcus
Cg+
S. aureus
Staphylococcal scalded skin syndrome
Toxic shock syndrome
MRSA
Cg-
novobiocin susceptible
S. epidermidis
novobiocin resistant
S. saprophyticus
Bacillus
Bacillus anthracis
Anthrax
Bacillus cereus
Food poisoning
Listeria
Listeria monocytogenes
Listeriosis
Clostridia
Clostridium (spore-forming)
motile:
Clostridium difficile
Pseudomembranous colitis
Clostridium botulinum
Botulism
Clostridium tetani
Tetanus
nonmotile:
Clostridium perfringens
Gas gangrene
Clostridial necrotizing enteritis
Peptostreptococcus (non-spore forming)
Peptostreptococcus magnus
Mollicutes
Mycoplasmataceae
Ureaplasma urealyticum
Ureaplasma infection
Mycoplasma genitalium
Mycoplasma pneumoniae
Mycoplasma pneumonia
Anaeroplasmatales
Erysipelothrix rhusiopathiae
Erysipeloid
Retrieved from "https://en.wikipedia.org/w/index.php?title=Staphylococcus_aureus&oldid=807295815"
Categories:
Staphylococcus
Bacteriology
Gram-positive bacteria
Bacterial diseases
Pathogenic bacteria
Healthcare-associated infections
Bacteria described in 1884
Hidden categories:
CS1 maint: Explicit use of et al.
CS1 maint: Multiple names: authors list
All pages needing factual verification
Wikipedia articles needing factual verification from October 2011
Articles with 'species' microformats
All articles with unsourced statements
Articles with unsourced statements from May 2016
Articles with unsourced statements from February 2017
Articles with unsourced statements from January 2017
Use dmy dates from December 2010
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Wikispecies
Languages
العربية
Azərbaycanca
Bân-lâm-gú
Български
Català
Čeština
Dansk
Deutsch
Eesti
Español
Esperanto
Euskara
فارسی
Français
Galego
한국어
Hrvatski
Bahasa Indonesia
Íslenska
Italiano
עברית
Basa Jawa
Latina
Lietuvių
Magyar
Nederlands
日本語
Norsk
Norsk nynorsk
Polski
Português
Română
Русский
Scots
සිංහල
Simple English
Slovenščina
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Svenska
ไทย
Türkçe
Українська
Tiếng Việt
Walon
中文
Edit links
This page was last edited on 27 October 2017, at 02:52.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

key: html

type: local

value: div

attrs: id class

values: mw-page-base noprint

values: mw-head-base noprint

value: a

value: i

attrs: id class lang

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

value: th

attrs: colspan style

values: text-align: center; background-color: rgb(220,235,245)

value: tr

value: img

attrs: alt src width height srcset data-file-width data-file-height

attrs: href class

value: td

attrs: href title

values: text-align: left; width: 200px; font-size: 100%

values:
/wiki/Food_poisoning
mw-redirect
Food poisoning

values: List of microbiota species of the lower reproductive tract of women

values:
/wiki/Scalded_skin_syndrome
mw-redirect
Scalded skin syndrome

values: International Statistical Classification of Diseases and Related Health Problems

attrs: alt src width height class srcset data-file-width data-file-height

values:
/wiki/Beta_hemolysis
mw-redirect
Beta hemolysis

values:
/wiki/Bacterial_spore
mw-redirect
Bacterial spore

values:
/wiki/Binary_fission
mw-redirect
Binary fission

values:
/wiki/Scanning_electron_micrograph
mw-redirect
Scanning electron micrograph

values:
/wiki/Commensal_bacterium
mw-redirect
Commensal bacterium

values:
/wiki/Asymptomatic_infection
mw-redirect
Asymptomatic infection

values:
/wiki/Bacterial_colony
mw-redirect
Bacterial colony

values: This claim needs references to reliable sources. (May 2016)

values:
noprint Inline-Template Template-Fact
white-space:nowrap;

values:
/wiki/Bloodstream_infection
mw-redirect
Bloodstream infection

values:
/wiki/Disease_vector
mw-redirect
Disease vector

values:
/wiki/Panton-Valentine_leukocidin
mw-redirect
Panton-Valentine leukocidin

values: This claim needs references to reliable sources. (February 2017)

values: Edit section: Strategies for post-transcriptional regulation by 3'untranslated region

values: Edit section: Other immunoevasive strategies

values:
/wiki/Immunoaffinity_chromatography
mw-redirect
Immunoaffinity chromatography

values:
/wiki/Neutrophil_granulocyte
mw-redirect
Neutrophil granulocyte

values:
/wiki/Mouse_model
mw-redirect
Mouse model

values: This claim needs references to reliable sources. (January 2017)

values: Edit section: Rapid diagnosis and typing

values:
/wiki/Quantitative_PCR
mw-redirect
Quantitative PCR

values:
/wiki/Bacteriophage_typing
mw-redirect
Bacteriophage typing

values: wikinews:Supergerm deaths soar, surpass AIDS in the United States

values:
/wiki/Triple_antibiotic_ointment
mw-redirect
Triple antibiotic ointment

values:
/wiki/Penicillin-binding_protein
mw-redirect
Penicillin-binding protein

values:
/wiki/30S_ribosomal_subunit
mw-redirect
30S ribosomal subunit

values:
/wiki/Antibiotic_resistance
mw-redirect
Antibiotic resistance

values: U.S. Centers for Disease Control and Prevention

values:
/wiki/Quaternary_ammonium
mw-redirect
Quaternary ammonium

values:
/wiki/Nosocomial_infection
mw-redirect
Nosocomial infection

attrs: alt src title width height srcset data-file-width data-file-height

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11717286

values: Category:CS1 maint: Explicit use of et al.

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6369479

values:
nofollow
external text
//doi.org/10.1093%2Fclinids%2F6.1.122

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9227864

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26016486

values:
nofollow
external text
//doi.org/10.1128%2FCMR.00134-14

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11687441

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19821358

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25332378

values:
nofollow
external text
//doi.org/10.1099%2Fmic.0.083485-0

values: Category:CS1 maint: Multiple names: authors list

values:
nofollow
external text
http://www.dictionary.com/browse/aureus

values:
nofollow
external text
//doi.org/10.1002%2Fjor.22672

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23133387

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25155269

values:
nofollow
external text
//doi.org/10.1111%2Fmmi.12767

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27730630

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/28260936

values:
nofollow
external text
//doi.org/10.2147%2FCCID.S130013

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6447271

values:
/wiki/ABIM_Foundation
mw-redirect
ABIM Foundation

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18646096

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21162635

values:
nofollow
external text
//doi.org/10.2217%2Ffmb.10.155

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25875834

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17678561

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19949556

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18978975

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14503727

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10627489

values:
nofollow
external text
//doi.org/10.1128%2Fcmr.13.1.16-34.2000

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11123352

values:
nofollow
external text
//doi.org/10.4049%2Fjimmunol.166.1.669

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12682126

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10524952

values:
nofollow
external text
//doi.org/10.1086%2F313461

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11888586

values:
nofollow
external text
//www.worldcat.org/issn/1553-7374

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20300607

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20532214

values:
nofollow
external text
//www.worldcat.org/issn/0305-1048

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20511587

values:
nofollow
external text
//doi.org/10.1093%2Fnar%2Fgkq462

values:
nofollow
external text
//doi.org/10.1038%2Fnsmb.2193

values:
nofollow
external text
http://jb.asm.org/content/194/11/2924

values:
nofollow
external text
//www.worldcat.org/issn/0021-9193

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22493015

values:
nofollow
external text
//doi.org/10.1128%2FJB.06708-11

values:
nofollow
external text
//www.worldcat.org/issn/0300-8584

values:
nofollow
external text
//www.worldcat.org/issn/1098-5522

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25092913

values:
nofollow
external text
//doi.org/10.1128%2FIAI.02002-14

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24367275

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7701329

values:
nofollow
external text
//doi.org/10.1126%2Fscience.7701329

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3679545

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18193895

values:
nofollow
external text
//doi.org/10.1021%2Fbi7014597

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16861688

values:
nofollow
external text
//doi.org/10.1128%2FIAI.00204-06

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16009720

values:
nofollow
external text
//doi.org/10.1084%2Fjem.20050846

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18276850

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1153018

values:
nofollow
external text
http://www.horizonpress.com/staph

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18718557

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16207977

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6751182

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9860802

values:
nofollow
external text
//doi.org/10.1161%2F01.CIR.98.25.2936

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19207079

values:
nofollow
external text
//doi.org/10.1086%2F597031

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11294701

values:
nofollow
external text
//doi.org/10.3201%2Feid0702.010204

values:
nofollow
external text
//www.worldcat.org/issn/1478-7210

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11014183

values:
nofollow
external text
//doi.org/10.1038%2F35030019

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8218273

values:
nofollow
external text
//doi.org/10.1021%2Fbi00096a006

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.1.5219.124-a

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11418528

values:
nofollow
external text
//doi.org/10.1093%2Fjac%2F48.1.143

values: The material near this tag needs to be fact-checked with the cited source(s). (October 2011)

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12390067

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9249217

values:
nofollow
external text
//doi.org/10.1093%2Fjac%2F40.1.135

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12672861

values:
nofollow
external text
//doi.org/10.1056%2FNEJMoa025025

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15811021

values:
nofollow
external text
//www.worldcat.org/issn/0022-2151

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9775288

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17472720

values:
nofollow
external text
//www.worldcat.org/issn/1473-3099

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16310147

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18337614

values:
nofollow
external text
//doi.org/10.1056%2FNEJMc0706805

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10655374

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17205449

values:
nofollow
external text
//doi.org/10.1086%2F510681

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/28143674

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26015481

values:
nofollow
external text
//doi.org/10.1128%2FIAI.00258-15

values: -moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;

values:
nofollow
http://www.cell.com/biophysj/
external text

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25185544

values:
nofollow
external text
//doi.org/10.1016%2Fj.bpj.2014.07.029

values:
nofollow
external text
http://www.stopmrsanow.org

values:
nofollow
external text
http://www.themrsa.com

values: Template talk:Gram-positive firmicutes diseases

values:
/wiki/Gram-positive_bacterial_infection
mw-redirect
Gram-positive bacterial infection

values: ICD-10 Chapter I: Certain infectious and parasitic diseases

values: List of ICD-9 codes 001–139: infectious and parasitic diseases

values:
/wiki/Alpha-hemolytic_streptococci
mw-redirect
Alpha-hemolytic streptococci

values:
/wiki/Streptococcus_milleri_group
mw-redirect
Streptococcus milleri group

values:
/wiki/Beta-hemolytic_streptococci
mw-redirect
Beta-hemolytic streptococci

values:
/wiki/Pseudomembranous_colitis
mw-redirect
Pseudomembranous colitis

values:
/wiki/Peptostreptococcus_magnus
mw-redirect
Peptostreptococcus magnus

values: nowraplinks hlist collapsible autocollapse navbox-inner

values: Category:All pages needing factual verification

values: Category:Wikipedia articles needing factual verification from October 2011

values: Category:Articles with 'species' microformats

values: Category:All articles with unsourced statements

values: Category:Articles with unsourced statements from May 2016

values: Category:Articles with unsourced statements from February 2017

values: Category:Articles with unsourced statements from January 2017

values: Category:Use dmy dates from December 2010

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/Staphylococcus_aureus
View the content page [ctrl-alt-c]
c

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values: Past revisions of this page [ctrl-alt-h]

values: p-views navigation vectorTabs p-views-label

values:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

values:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

values:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

values: Featured content – the best of Wikipedia

values: Find background information on current events

values:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

values: portal navigation p-navigation p-navigation-label

values: Guidance on how to use and edit Wikipedia

values: About the project, what you can do, where to find things

values: A list of recent changes in the wiki [ctrl-alt-r]

values: portal navigation p-interaction p-interaction-label

values: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

values: Recent changes in pages linked from this page [ctrl-alt-k]

values:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

values: A list of all special pages [ctrl-alt-q]

values: Permanent link to this revision of the page

values: Link to connected data repository item [ctrl-alt-g]

values: Printable version of this page [ctrl-alt-p]

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values:
uls-settings-trigger
Language settings
0
button
true

values: مكورة عنقودية ذهبية – Arabic

values: Staphylococcus aureus – Chinese (Min Nan)

values: استافیلوکوکوس اورئوس – Persian

values: 황색포도상구균 – Korean

values: 黄色ブドウ球菌 – Japanese

values: Золотистый стафилококк – Russian

values: ස්ටැෆිලොකොකස් ඕරියස් – Sinhala

values: Стафилококус ауреус – Serbian

values: Стафілокок золотистий – Ukrainian

values: 金黃色葡萄球菌 – Chinese

values: /static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x

values: /static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x

values:
suggestions
display: none; font-size: 13px;

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Staphylococcus_aureus rootpage-Staphylococcus_aureus vector-experimental-print-styles vector-nav-directionality skin-vector action-view